Pharma Journalist -

BioCryst Pharmaceuticals, Inc. announced that oral, once-daily ORLADEYO (berotralstat) is now available for patients with a prescription in Germany. ORLADEYO was approved by the…
Read More...

Moderna, Inc. announced that it has entered into an additional agreement with Lonza to support drug substance manufacturing for its global supply chain. The agreement will establish a…
Read More...

MorphoSys AG and Constellation Pharmaceuticals, Inc. announced that they have entered into a definitive agreement whereby MorphoSys will acquire Constellation for $34.00 per share in…
Read More...

Centivax Inc. announced that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development of Centi-B9, Centivax's…
Read More...

Primordial Genetics a synthetic biology company developing enzymatic production systems for nucleic acids,  announced granting Arcturus Therapeutics Holdings Inc. a clinical-stage…
Read More...

GenScript Biotech Corporation along with its subsidiary, GenScript ProBio, and Ligand Pharmaceuticals Incorporated announced that they have entered into a strategic licensing agreement…
Read More...

SMi Reports: As part of SMi’s leading Injectables series, this year’s event will address the key drivers of the pre-filled syringes and combination products industry Delegates stand…
Read More...

Amgen and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083, which is Kyowa Kirin's potential first-in-class, Phase 3-ready anti-OX40 fully human…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that it has entered into an agreement with Thermo Fisher Scientific (NYSE: TMO)…
Read More...

POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, announced today that the U.S.…
Read More...